Pre-Clinical Stage Antibody Drug Conjugates in Active Development – 2021
90 Antibody Drug Conjugates Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
Tag: Antibody Drug Conjugates
Approved Monoclonal Antibodies for Cancer Treatment
In 1986, muromonab-CD3 (OKT3) wins the first therapeutic monoclonal antibody approval from the US FDA, which works as an immunosuppressive ...